Q2 2022 13F Holders as of 6/30/2022
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
2.53B
-
Number of holders
-
2943
-
Total 13F shares, excl. options
-
1.65B
-
Shares change
-
+33M
-
Total reported value, excl. options
-
$150B
-
Value change
-
+$3.01B
-
Put/Call ratio
-
0.78
-
Number of buys
-
1459
-
Number of sells
-
-1162
-
Price
-
$91.17
Significant Holders of Merck & Co., Inc. - Common Stock (MRK) as of Q2 2022
3,150 filings reported holding MRK - Merck & Co., Inc. - Common Stock as of Q2 2022.
Merck & Co., Inc. - Common Stock (MRK) has 2,943 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1.65B shares
of 2.53B outstanding shares and own 65.25% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (221M shares), STATE STREET CORP (118M shares), GEODE CAPITAL MANAGEMENT, LLC (46M shares), WELLINGTON MANAGEMENT GROUP LLP (40.7M shares), BANK OF AMERICA CORP /DE/ (38.9M shares), MORGAN STANLEY (38M shares), Bank of New York Mellon Corp (32.6M shares), NORTHERN TRUST CORP (29.9M shares), CHARLES SCHWAB INVESTMENT MANAGEMENT INC (29.5M shares), and MASSACHUSETTS FINANCIAL SERVICES CO /MA/ (27.7M shares).
This table shows the top 2943 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.